ILCA School of Liver Cancer 2021, Aarhus, Denmark

HomeEducationILCA School of Liver Cancer 2021, Aarhus, Denmark

ILCA School of Liver Cancer 2021, Aarhus, Denmark

ILCA is very pleased to announce that the next edition of the ILCA School of Liver Cancer, Aarhus, Denmark, will be virtual this May 2021.

The ILCA School will assemble multi-disciplinary experts on hepatocellular carcinoma and cholangiocarcinoma from Aarhus University Hospital, University of Copenhagen and specialists, exclusively invited from Scandinavia, the USA, Spain and France.

The event will to provide a summary of the current state-of-the- art knowledge of the pathogenesis and clinical management of hepatocellular carcinoma and the research conducted internationally. In addition, the participants will be exposed to the clinical management of HCC and cholangiocarcinoma and critical sessions discussing clinical trials.

Sign today to get the deepest knowledge on:

  • Recent developments in the genomics of liver cancer and their therapeutic implications.
  • Current indications for resection and transplantation vis-a-vis medical and non-surgical locoregional modalities.
  • The systemic current management of HCC and intrahepatic cholangiocarcinoma and the opportunities of improvement in the near future.

Programme

Friday 7 May
08:30 – 08:45 Introduction to the ILCA School of Liver Cancer
Gerda Elisabeth Villadsen, MD, PhD, Ass. Professor, Aarhus University Hospital, DenmarkWelcome note
Chief Medical Officer Jørgen Schøler Kristensen, Aarhus University Hospital, Denmark
08:45 – 09:00 Interactive quiz – session warm up
Henning Grønbæk, MD, PhD, Professor & Consultant, Aarhus University Hospital,  Denmark
OVERVIEW OF MANAGEMENT OF HCC
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Frank Viborg Mortensen, MD, DMSc, Professor, HBP surgery, Aarhus University Hospital, Denmark)
09:00 – 09:20 Epidemiology and Surveillance for HCC
Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark
09:20 – 09:35 Fast Track and Multidisciplinary Approach to HCC
Gerda Elisabeth Villadsen MD, PhD, Aarhus University Hospital, Denmark
09:35 – 09:45 Discussion
09:45 – 10:00 Virtual Coffee Break
PATHOLOGY, ONCOGENOMICS, CIRCULATING TUMOR DNA AND TUMOR CELLS
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Britta Weber, MD, PhD, Aarhus University Hospital, Denmark)
10:00- 10:20 Biopsy Diagnosis and Pathology Profiling
Stephen J.  Hamilton Dutoit, MD, Professor, Aarhus University Hospital, Denmark
10:20 – 10:50 Oncogenomics in HCC and Cholangiocarcinoma
Jesper Bøje Andersen, MSc, PhD University of Copenhagen, Denmark
10:55 – 11:15 Circulating Tumor DNA and Tumor Cells in HCC
Jens  Kelsen, MD, PhD, Aarhus University Hospital, Denmark
11:15 – 11:35 Discussion
11:35 – 11:50 Virtual Coffee Break
IMAGING OF HCC
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Morten Høyer, MD, PhD, Professor, Aarhus University Hospital, Denmark)
11:50 – 12:15 The role of imaging (US, CT, MRI) in HCC
Lars Peter Larsen, MD, PhD, Aarhus University Hospital, Denmark
12:25 – 12:45 The role of Molecular Imaging in HCC
Michael Sørensen, MD, PhD, Aarhus University Hospital, Denmark
12:45 – 13:00 Discussion
13:00 – 13:45 Virtual Lunch Break
13:45 – 14:00 Interactive quiz – session warm up
Henning Grønbæk, MD, PhD, Professor & Consultant, Aarhus University Hospital,  Denmark
SURGERY IN HCC AND CHOLANGIOCARCINOMA
(Chair: Nicolai Aagaard Schultz , MD PhD, Liver Surgery, Rigshospitalet , Copenhagen, Denmark & Kirsten Muri Boberg professor , Oslo University Hospital, Norway & Magnus Ritzell ,  Head of Liver Surgery, Gotenburg University Sweden)
14:00 – 14:20 Preoperative Evaluation of Liver Function Before Resection
Niels Kristian Aagaard, MD, PhD, Aarhus University Hospital, Denmark
14:20 – 14:40 Resection of HCC in a Cirrhotic Liver
Bård Røsok, MD, PhD, Oslo University Hospital, Norway
14:40 – 15:10 HCC, Surgery and Liver  transplantation: Is it Time to Abandon the Milan Criteria?
Myron Schwartz, MD, Professor, Mount Sinai Hospital, New York, US
15:10 – 15:40 Surgery and Transplantation for Cholangiocarcinoma
Eric Vibert, MD, PhD, Professor, Université Paris Saclay, France
15:40 – 16:10 Discussion
16:10 – 16:25 Virtual Coffee Break
INTRODUCTION TO SYSTEMIC THERAPY IN HCC
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Kirsten Vistisen,  MD, PhD, Herlev University Hospital,  University of Copenhagen, Denmark)
16:25 – 17:00 Advanced HCC Systemic Therapy – from Sorafenib to immunotherapy  
Richard Finn, MD, Professor, UCLA, California, US
17:00 – 17:15 Discussion
Saturday 8 May
08:30 – 08:45 Highlights From Day 1
Henning Grønbæk, MD, PhD, Professor & Consultant, Aarhus University Hospital,  Denmark
LOCOREGIONAL  TREATMENT FOR HCC
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Gerda Elisabeth Villadsen MD, PhD, Aarhus University Hospital, Denmark)
08:45 – 09:15 The Role of Ablation and TACE for HCC
Maria Reig, MD, DMSc, Professor, University of Barcelona, Spain
09:15 – 09:45 The Role of Radioembolisation in HCC
Bruno Sangro, MD, PhD, Professor University of Navarra, Spain
09:45 – 10:05 Discussion
10:05 – 10:20 Virtual Coffee Break
RADIOTHERAPY IN PRIMARY LIVER CANCER
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Hanna R. Mortensen, MD, PhD, Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark)
10:20 – 10:40 Stereotactic Body Radiotherapy for Liver Cancer
Britta Weber, MD, PhD, Aarhus University Hospital, Denmark
10:40 – 11:00 Particle Therapy, a New Treatment for Liver Cancer
Morten Høyer, MD, PhD, Professor, Aarhus University Hospital, Denmark
SYSTEMIC TREATMENTS FOR HCC AND CHOLANGIOCARCINOMA
(Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Britta Weber, MD, PhD, Aarhus University Hospital, Denmark)
11:15 – 11:35 Systemic Treatments in Cholangiocarcinoma
Morten Ladekarl, DMSc, Professor, Aalborg University Hospital, Denmark
11:35 – 11:55 Benefits and Risks of Immunotherapy
Inge Marie Svane, PhD, Professor, Herlev University Hospital, Denmark
11:55 – 12:15 Discussion
12:15 – 12:35 A patient perspective of living with HCC – what is important?
Tora Dahl, Danish Liver Association
12:35 – 12:45 Q&A
12:45 – 13:00 Closing Remarks
Gerda Elisabeth Villadsen MD, PhD, Ass. Professor, Aarhus University Hospital, Denmark